Figure 1 | Scientific Reports

Figure 1

From: Comparison of early and late Pneumocystis jirovecii Pneumonia in kidney transplant patients: the Korean Organ Transplantation Registry (KOTRY) Study

Figure 1

Prophylaxis regimens for Pneumocystis jirovecii pneumonia in Korea. (a) PJP prophylaxis policy of 32 transplantation centers. Indicated prophylaxis was applied to patients that had received desensitization, ATG or rituximab, or received anti-rejection therapy. (b) Duration of PJP prophylaxis. (c) Dose of for PJP prophylaxis. ATG, anti-thymocyte globulin; PJP, Pneumocystis jirovecii pneumonia; SMP, sulfamexothazole; TMP, trimethoprim.

Back to article page